U.S. flag

An official website of the United States government

Display Settings:

Format
Sort by

Send to:

Choose Destination

Links from Books

Items: 2

1.
Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations
Laura M. Spring, Mark L. Zangardi, Beverly Moy, Aditya Bardia
Oncologist. 2017 Sep; 22(9): 1039–1048. Published online 2017 Jul 13. doi: 10.1634/theoncologist.2017-0142
PMCID:
PMC5599204
AbstractArticlePDF–1.0M
2.
MONARCH 1, a phase 2 study of abemaciclib, a CDK4 and CDK6 inhibitor, as a single agent, in patients with refractory HR+/HER2− metastatic breast cancer
Maura N. Dickler, Sara M. Tolaney, Hope S. Rugo, Javier Cortés, Véronique Diéras, Debra Patt, Hans Wildiers, Clifford A. Hudis, Joyce O’Shaughnessy, Esther Zamora, Denise A. Yardley, Martin Frenzel, Andrew Koustenis, José Baselga
Clin Cancer Res. Author manuscript; available in PMC 2018 Sep 1.
Published in final edited form as: Clin Cancer Res. 2017 Sep 1; 23(17): 5218–5224. Published online 2017 May 22. doi: 10.1158/1078-0432.CCR-17-0754
Correction in:
Clin Cancer Res. 2018 Nov 1; 24(21): 5485.
PMCID:
PMC5581697
AbstractArticlePDF–168K

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center